Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Zolgensma
Zolgensma
Novartis Admits to ‘Mistake’ After Partial Clinical Hold Placed on Zolgensma Trial
RAPS.org
Thu, 10/31/19 - 11:54 pm
Novartis
Zolgensma
clinical trials
SMA
FDA
Oooooh, That’s Scary! Welcome to the Dark Side of Biopharma
BioSpace
Thu, 10/31/19 - 10:37 am
CRISPR
drug pricing
Novartis
Zolgensma
bioterrorism
Elizabeth Holmes
Martin Shkreli
Novartis’ Zolgensma gene therapy study halted by FDA on animal safety concerns
Stat
Wed, 10/30/19 - 10:32 am
Novartis
Zolgensma
FDA
gene therapy
clinical trials
SMA
Zolgensma hits the ground running, says Novartis
Pharmaforum
Tue, 10/22/19 - 10:33 am
Novartis
Zolgensma
AveXis
SMA
payers
Novartis' latest Zolgensma data bode well for use in older patients
Fierce Pharma
Mon, 10/7/19 - 12:13 pm
Novartis
Zolgensma
SMA
FDA
spinal muscular atrophy
Novartis to put AveXis into protective custody after data manipulation scandal
Fierce Pharma
Tue, 09/24/19 - 10:17 pm
Novartis
AveXis
Zolgensma
Novartis in political row after denying Belgian toddler compassionate access to gene therapy
Pharmaforum
Tue, 09/24/19 - 10:01 am
Novartis
Zolgensma
SMA
compassionate use guidelines
Novartis, shadowed by data scandal, renews case for Zolgensma
Biopharma Dive
Thu, 09/19/19 - 09:56 am
Novartis
Zolgensma
SMA
spinal muscular atrophy
Novartis Makes New Data Integrity Commitment
RAPS.org
Mon, 09/9/19 - 11:22 am
Novartis
data
data integrity
Vas Narasimhan
Zolgensma
Novartis earlier acknowledged Zolgensma data errors to FDA but blamed them on poor reporting
Fierce Pharma
Tue, 08/27/19 - 12:06 pm
Novartis
AveXis
Zolgensma
FDA
FDA asks why Novartis took two months to launch formal internal probe, after AveXis flagged data manipulation
Endpoints
Fri, 08/23/19 - 10:17 am
Novartis
FDA
Zolgensma
AveXis
AveXis scientific founder fires back at Novartis CEO Vas Narasimhan, 'categorically denies any wrongdoing'
Endpoints
Mon, 08/19/19 - 11:36 pm
Novartis
AveXis
Brian Kaspar
Vas Narasimhan
Zolgensma
Novartis CEO Says FDA Process Could Have Been Handled Better
Bloomberg
Mon, 08/19/19 - 10:33 am
Novartis
Pharma CEOs
Vas Narasimhan
Zolgensma
Novartis to answer U.S. Senate demand for data manipulation details
Yahoo/Reuters
Mon, 08/19/19 - 09:55 am
Novartis
Senate
Zolgensma
AveXis scientific founder is out as Novartis names a new CSO in wake of an ethics scandal
Endpoints
Wed, 08/14/19 - 11:15 am
Novartis
AveXis
Zolgensma
FDA
Novartis inspection puts into question who knew what—and when—about Zolgensma data manipulation
Fierce Pharma
Tue, 08/13/19 - 11:20 pm
Novartis
FDA
Zolgensma
5 Biggest New Drugs Approved in 2019 So Far
Motley Fool
Tue, 08/13/19 - 11:43 am
drug approvals
FDA
AbbVie
JNJ
Novartis
Pfizer
Skyrizi
psoriasis
Vyndaqel
Zolgensma
SMA
Mayzent
multiple sclerosis
Balversa
metastatic bladder cancer
Questions pile up for Novartis as senators call on FDA to take action
Endpoints
Tue, 08/13/19 - 11:41 am
Novartis
FDA
Senate
Zolgensma
5 Reasons Novartis Shareholders Aren't Shaken
Yahoo/Motley Fool
Mon, 08/12/19 - 10:32 am
Novartis
Zolgensma
FDA
shareholders
Entresto
Novartis resolute that it acted in good faith on Zolgensma
BioCentury
Wed, 08/7/19 - 11:54 pm
Novartis
data
Zolgensma
FDA
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »